ALMS — AI Stock Analysis & Recommendation
TradeFlare's AI research teams rate ALMS a HOLD with a conviction of 35/100. The current price is $9.9.
- Entry: $9.9
- Target: $12.38
- Stop: $8.42
The technicals are bearish and the risk profile is high, necessitating a cautious approach despite positive fundamental signals. Catalysts to watch: Progress towards NDA submission for envudeucitinib; Analyst 'strong_buy' consensus and high mean target price; Continued insider buying activity. Key risks: Recent Phase 2b trial miss for envudeucitinib in the overall lupus population; High realized volatility and significant 1-year drawdown; Bearish technical trend with price below key moving averages.
FlareScore breakdown — Technical: 75 · Fundamental: 75 · Sentiment: 60 · Risk: 10
Frequently asked questions
Is ALMS a buy? TradeFlare's AI currently rates ALMS a HOLD with 35/100 conviction.
What is the price target for ALMS? TradeFlare's AI price target for ALMS is $12.38.
Last updated September 11, 2026 · AI-generated analysis for informational purposes, not financial advice.